| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 北京市春立正达医疗器械股份有限公司(688236+01858.HK)成立于1998年,是一家专业从事人工关节和脊柱产品、运动医学产品的研发、生产、行销的A+H上市企业。公司拥有42个产品注册证书,是国内人工关节领域注册证较为齐全的企业,涵盖髋、膝、肩、肘等四大类关节产品。春立医疗是中国大陆较早获批BIOLOXdelta第四代全陶及半陶关节注册证的企业,同时也是国内较早拥有BIOLOXOPTION带锥套陶瓷头注册证的企业,打破了陶瓷关节国际品牌垄断的格局。与此同时,春立医疗成功研发出单髁膝关节产品,同时拥有固定平台单髁与活动平台单髁,填补了国内关节领域的空白,并且春立产品已经出口到世界47个国家和地区。春立医疗成立23年来,拥有千余名员工,包括博士后、博士、MBA、硕士、本科及15年以上行业经验等专业技术人才。人才建设涵盖机械设计、材料、生物力学、临床医学、电脑等多学科的复合型专业团队。公司拥有国家高新技术企业、北京市人工关节工程实验室、北京市企业技术中心等资质。承担了科技部人才计画项目国家自然科学基金和中国博士后科学基金并多次承担北京市科委、发改委、经信委等政府科研项目,是国产标准人工关节与定制关节的领军者,打破了国外垄断,提升了我国关节领域自主创新的水准。作为民族关节行业的领军者,春立医疗将继续“秉承前人之精华,研发世人之精品”,以“视如己用,不断创新”作为产品研发、生产的理念,设计符合国人特性的假体,面向全球客户提供优质产品,成为有世界知名度的骨科企业。 | ||||||||||||||||||||||||
| Main Business | 骨科医疗器械的生产、研发与销售 | ||||||||||||||||||||||||
| Legal Representative | 史文玲 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 张丽丽 | ||||||||||||||||||||||||
| Solicitors | 北京市浩天信和律师事务所 | ||||||||||||||||||||||||
| Auditors | 大信会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 010-87361998 | ||||||||||||||||||||||||
| Fax No | 010-58611751 | ||||||||||||||||||||||||
| Website | www.clzd.com | ||||||||||||||||||||||||
| ir@clzd.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 30/12/2021 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.720 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.362 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 7.502 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 1.060B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |